{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:41:50Z","timestamp":1791870110434,"version":"4.3.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41574-024-01073-w","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T09:41:47Z","timestamp":1733305307000},"page":"69-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in basic biology and translation in islet research"],"prefix":"10.1038","volume":"21","author":[{"given":"Carmella","family":"Evans-Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","volume":"187","author":"ED Abel","year":"2024","unstructured":"Abel, E. D. et al. Diabetes mellitus-progress and opportunities in the evolving epidemic. Cell 187, 3789\u20133820 (2024).","journal-title":"Cell"},{"key":"1073_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126742","volume":"4","author":"ME Capozzi","year":"2019","unstructured":"Capozzi, M. E. et al. \u03b2 cell tone is defined by proglucagon peptides through cAMP signaling. JCI Insight 4, e126742 (2019).","journal-title":"JCI Insight"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-023-00944-2","volume":"6","author":"JL Huang","year":"2024","unstructured":"Huang, J. L. et al. Paracrine signalling by pancreatic \u03b4 cells determines the glycaemic set point in mice. Nat. Metab. 6, 61\u201377 (2024).","journal-title":"Nat. Metab."},{"key":"1073_CR4","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s42255-024-01139-z","volume":"6","author":"TG Hill","year":"2024","unstructured":"Hill, T. G. et al. Loss of electrical \u03b2-cell to \u03b4-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes. Nat. Metab. 6, 2070\u20132081 (2024).","journal-title":"Nat. Metab."},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/dom.15002","volume":"25","author":"EG Hoffman","year":"2023","unstructured":"Hoffman, E. G. et al. Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes. Diabetes Obes. Metab. 25, 1547\u20131556 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s42255-023-00962-0","volume":"6","author":"X Peng","year":"2024","unstructured":"Peng, X. et al. Readily releasable \u03b2 cells with tight Ca2+-exocytosis coupling dictate biphasic glucose-stimulated insulin secretion. Nat. Metab. 6, 238\u2013253 (2024).","journal-title":"Nat. Metab."},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.cmet.2024.06.001","volume":"36","author":"J Kolic","year":"2024","unstructured":"Kolic, J. et al. Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease. Cell Metab. 36, 1619\u20131633.e5 (2024).","journal-title":"Cell Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01073-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T01:01:27Z","timestamp":1736989287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01073-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-01073-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"4 December 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.E.-M. has served on advisory boards related to type\u00a01 diabetes mellitus research clinical trial initiatives: Provention Bio, Dompe, Isla Technologies, and MaiCell Technologies. C.E.-M. serves as President of the Immunology of Diabetes Society (IDS), Co-Executive Director of nPOD, Investigator and Study Chair in TrialNet, and Co-PI of the NIH Integrated Islet Distribution Program (IIDP). These activities have not dealt directly with topics covered in this manuscript. C.E.-M. is a co-inventor on Patent (16\/291,668): Extracellular Vesicle Ribonucleic Acid (RNA) Cargo as a Biomarker of Hyperglycemia and Type 1 Diabetes. C.E.-M. has received investigator-initiated grant funding from Astellas and Lilly Pharmaceuticals and in-kind research support from BMS and Nimbus.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}